2012, № 12 (148)

1. Ocular manifestations of diabetes / Ed. Balashevich L.I. – St. Petersburg, 2004. – 382 p.

2. Libman E.S., Shahova E.V. Blindness and disability due to pathology of the vision in Russia // Journal of Ophthalmology. – 2006. – №1. – P. 35-37.

3. Slepova O.S., Neroev V.V. Ilyukhin P.A., Sarygina O.I. Immunological control of in the surgical treatment of patients with proliferative diabetic retinopathy with preliminary introduction to the vitreous Lucentis / / Russian Ophthalmological Journal. – 2012. – №1. – P.69-74.

4. Chernykh V.V., Lysikov A.G., Obukhova O.O., Gorbenko O.M., Shvayuk A.P., Trunov A.N. Features of local immunoinflammatory process at nonproliferative diabetic retinopathy // Bulletin of the Novosibirsk State University.– 2011. – Vol.9, №1. – P.164-168.

5. Khodzhayev N.S., Chernykh V.V., Romenskaya I.V., Kuntysheva K.E., Trunov A.N. Effect of lasercoagulation retina on clinical-laboratory parameters in patients diabetic macular edema / / Bulletin of the Novosibirsk State University.– 2011. – Vol.9, №4. – P.48-53.

6. Bhavsar A.R. Diabetic retinopathy: the latest in current management // Retina. – 2006. – Vol. 26, №6. – P. 71-79.

7. Citirik M., Kabatas E.U., Batman C., Akin K.O., Kabatas N. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy // Ophthalmic Res.-2012.– Vol.47, №1.– Р.7-12.

8. Lim A., Stewart J., Chui T.Y., Lin M., Ray K., Lietman T., Porco T., Jung L., Seiff S., Lin S. Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population. // Ophthalmic Epidemiol. – 2008. – №6. -Р. 402-409.

9. Kollias A.N., Ulbig M.W. Diabetic retinopathy: Early diagnosis and effective treatment // Dtsch. Arztebl. Int. -2010.– №5.– P. 75-83.

10. Kowluru R.A., Zhong Q., Kanwar M. Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes // Exp. Eye Res.-2010. – №5.-Р. 617-623.

11. Murugeswari P., Shukla D., Rajendran A., Kim R., Namperumalsamy P., Muthukkaruppan V. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease // Retina.– 2008. -№6. – Р. 817-824.

12. Pennock S., Kazlauskas A. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses // Mol. Cell Biol.-2012.-Vol.32,№10.-Р.1955-1966.

13. Rasier R., Gormus U., Artunay O., Yuzbasioglu E., Oncel M., Bahcecioglu H. Vitreous levels of VEGF, IL-8, and TNF-alpha in retinal detachment // Curr. Eye Res.-2010. – Vol.35, №6.– Р.– 505-509.

14. Symeonidis C, Papakonstantinou E, Androudi S, Rotsos T, Diza E, Brazitikos P, Karakiulakis G, Dimitrakos S.A. Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy // Cytokine.– 2011. – Vol.54, №2. – Р. 212-217.

15. Sadaka A., Giuliari G.P. Proliferative vitreoretinopathy: current and emerging treatments // Clin. Ophthalmol. – 2012. –№6. -Р. 1325-1333.

About this article